Repligen Q2 Adj. EPS $0.54 Beats $0.45 Estimate, Sales $204.128M Beat $201.483M Estimate
Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.45 by 20 percent. This is a 45.95 percent increase over earnings of $0.37 per share from the same
Repligen made more money than experts thought it would in the last three months—the company earned more per share and sold more stuff than people predicted. When a company beats what people expected, it usually means the business is doing better than planned, which is something to notice when checking how well the company is running.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.